InvestSMART

Nanoveu Limited (ASX: NVU) - Announcements

Current share price for NVU : $0.060 0.002 (3.45%)+

ASX company news and announcements for Nanoveu Limited (NVU) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Nanoveu Limited (NVU) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Nanoveu Limited (NVU), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Nanoveu Limited (NVU)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$65 Application for quotation of securities - NVU 3 Jan 2025 5:39PM $0.036 $0.060 risen by 66.67%
$65 Application for quotation of securities - NVU 3 Jan 2025 5:39PM $0.036 $0.060 risen by 66.67%
$65 Results of Meeting 23 Dec 2024 4:35PM $0.033 $0.060 risen by 81.82%
$65 EyeFly3D USD 850K Purchase Order Received 23 Dec 2024 9:25AM $0.030 $0.060 risen by 100%
$65 USA Patent Granted for Next-Generation Vision AI Hardware 12 Dec 2024 9:22AM $0.038 $0.060 risen by 57.89%
$65 EMASS Commences Real-World Integrations of ECS-Dot Chipset 28 Nov 2024 8:17AM $0.042 $0.060 risen by 42.86%
$65 Application for quotation of securities - NVU 27 Nov 2024 6:21PM $0.042 $0.060 risen by 42.86%
$65 General Meeting Letter to Shareholders 22 Nov 2024 4:35PM $0.046 $0.060 risen by 30.43%
$65 Notice of General Meeting/Proxy Form 22 Nov 2024 4:34PM $0.046 $0.060 risen by 30.43%
$65 Application for quotation of securities - NVU 22 Nov 2024 12:56PM $0.046 $0.060 risen by 30.43%
$65 Proposed issue of securities - NVU 18 Nov 2024 7:55PM $0.050 $0.060 risen by 20%
$65 CLEANSING PROSPECTUS 18 Nov 2024 7:31PM $0.050 $0.060 risen by 20%
$65 EMASS to Embed ReRAM Technology 18 Nov 2024 9:22AM $0.048 $0.060 risen by 25%
$65 EMASS SoC Excels in Image Recognition & Voice Command Tests 12 Nov 2024 9:07AM $0.065 $0.060 fallen by 7.69%
$65 Change of Director's Interest Notice 8 Nov 2024 9:33AM $0.053 $0.060 risen by 13.21%
$65 Nanoveu to Commence Next Phase Benchmarking for EMASS SoC 6 Nov 2024 9:30AM $0.037 $0.060 risen by 62.16%
$65 Quarterly Activities Report 31 Oct 2024 1:45PM $0.039 $0.060 risen by 53.85%
$65 Appendix 4C Cash Flow Report 31 Oct 2024 1:44PM $0.039 $0.060 risen by 53.85%
$65 EMASS Unveils New Compact AI Prototyping Board 28 Oct 2024 9:12AM $0.053 $0.060 risen by 13.21%
$65 EMASS Delivers Peer-Leading SoC Benchmark Results 22 Oct 2024 9:20AM $0.048 $0.060 risen by 25%
$65 Trading Halt 21 Oct 2024 2:55PM $0.043 $0.060 risen by 39.53%
$65 Pause in Trading 21 Oct 2024 2:40PM $0.048 $0.060 risen by 25%
$65 US$200,000 Order Received for EyeFly3D iPhone 16 Films 21 Oct 2024 9:15AM $0.043 $0.060 risen by 39.53%
$65 EMASS Testing System-on-a-Chip Semiconductor Technology 18 Oct 2024 9:17AM $0.038 $0.060 risen by 57.89%
$65 Update - Proposed issue of securities - NVU 16 Oct 2024 4:33PM $0.040 $0.060 risen by 50%

201 - 225 of 654 results

Page 9 of 27

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.